4//SEC Filing
Gold Daniel Allen 4
Accession 0001193125-25-325359
CIK 0001635088other
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 7:54 PM ET
Size
11.5 KB
Accession
0001193125-25-325359
Insider Transaction Report
Form 4
Gold Daniel Allen
Director
Transactions
- Sale
Common Shares
2025-12-16$22.93/sh−275,000$6,305,750→ 17,772,727 total(indirect: Held by QVT Financial Investment Cayman Ltd.) - Sale
Common Shares
2025-12-16$23.08/sh−642,282$14,823,869→ 17,130,445 total(indirect: Held by QVT Financial Investment Cayman Ltd.) - Sale
Common Shares
2025-12-17$23.05/sh−432,718$9,974,150→ 16,697,727 total(indirect: Held by QVT Financial Investment Cayman Ltd.) - Sale
Common Shares
2025-12-17$23.02/sh−155,076$3,569,850→ 16,542,651 total(indirect: Held by QVT Financial Investment Cayman Ltd.) - Sale
Common Shares
2025-12-17$23.17/sh−189,538$4,391,595→ 16,353,113 total(indirect: Held by QVT Financial Investment Cayman Ltd.)
Footnotes (1)
- [F1]The reporting person is one of three directors of QVT Financial Investment Cayman Ltd. ("QVT FIC"), sharing voting and investment control over the Common Shares held directly by QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.
Documents
Issuer
Roivant Sciences Ltd.
CIK 0001635088
Entity typeother
Related Parties
1- filerCIK 0001832142
Filing Metadata
- Form type
- 4
- Filed
- Dec 17, 7:00 PM ET
- Accepted
- Dec 18, 7:54 PM ET
- Size
- 11.5 KB